Colorectal Cancer Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Colorectal Cancer Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason.

The size of these pipelines ranges from 10 products in rectal cancer to 581 products in colorectal cancer. Across all three of these indications, however, kinases, immune-related proteins, DNA-related proteins and viral proteins are common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Colorectal Cancer Report Coverage 11
2.2 Anal Cancer - Overview 11
2.3 Rectal Cancer - Overview 11
2.4 Colorectal Cancer - Overview 11
3 Therapeutics Development 12
3.1 Anal Cancer 12
3.2 Rectal Cancer 16
3.3 Colorectal Cancer 18
4 Therapeutics Assessment 56
4.1 Anal Cancer 56
4.2 Rectal Cancer 63
4.3 Colorectal Cancer 71
5 Companies Involved in Therapeutics Development 100
5.1 Anal Cancer 100
5.2 Rectal Cancer 108
5.3 Colorectal Cancer 114
6 Dormant Projects 241
6.1 Anal Cancer 241
6.2 Rectal Cancer 241
6.3 Colorectal Cancer 242
7 Discontinued Products 261
7.1 Anal Cancer 261
7.2 Colorectal Cancer 261
8 Product Development Milestones 265
8.1 Anal Cancer 265
8.2 Rectal Cancer 278
8.3 Colorectal Cancer 280
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/colorectal-cancer-therapeutics-strategies-and-product-pipeline-review-2017/250073

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250073

More News From Daily Transparent

The Latest: US envoy to UN praises Kofi Annan's legacy

Aug 18, 2018

GENEVA — The Latest on the death of former U.N. secretary-general Kofi Annan (all times local): 5:10 p.m. The U.S. ambassador to the United Nations says former U.N. chief Kofi Annan "devoted his life to making the world a more peaceful place" and "worked tirelessly to unite us." Nikki Haley in a statement says the U.S. joins the U.N. and diplomatic community in celebrating the life of Annan, the first black African to become U.N. chief. He died in the early hours Saturday at age 80 after a short illness. Many world leaders from Britain to Germany to Nigeria to...

Former UN Secretary-General Kofi Annan dies at age 80

Aug 18, 2018

GENEVA — Kofi Annan, one of the world's most celebrated diplomats and a charismatic symbol of the United Nations who rose through its ranks to become the first black African secretary-general, has died. He was 80. His foundation announced his death in Switzerland's capital, Bern, on Saturday in a tweet , saying he died after a short unspecified illness. It did not give details and remembered the Nobel Peace Prize winner as "radiating genuine kindness, warmth and brilliance in all he did." The president of Ghana, where Annan was born, said in a tweet that "I am ... comforted by...

Tesla files lawsuit against Ontario government

Aug 18, 2018

TORONTO — Electric car maker Tesla Motors said Thursday it is suing Ontario's new government, claiming it was treated unfairly in the cancellation of a program providing rebates to residents who bought electric vehicles. Tesla Motors Canada said in court documents that the decision by Premier Doug Ford's conservative government to cancel the program in July left hundreds of customers ineligible for rebates they expected to get when they ordered their vehicles. It claims Tesla was singled out. In July, the government said the rebates would be honored for vehicles ordered through a dealership if they are delivered and registered...

Swedish police say suspect in car fires arrested in Turkey

Aug 18, 2018

COPENHAGEN, Denmark — A man suspected of arson in connection with dozens of car fires in Goteborg, Sweden's second largest city, has been arrested in Turkey, police said Wednesday. About 80 cars were set ablaze in the night from Monday to Tuesday, chiefly in Goteborg, and nearby Trollhattan, an industrial city. Fires were also reported on a smaller scale in Malmo, Sweden's third largest city. Police spokesman Thomas Fuxborg said Wednesday that a man in his 20s was arrested a day earlier as he tried to enter Turkey. He is suspected of arson and is expected to be returned to...

New Zealand bans most foreigners from buying homes

Aug 18, 2018

WELLINGTON, New Zealand — New Zealand has banned most foreigners from buying homes as it tries to tackle runaway housing prices. Previously the housing market was open to investors worldwide, but the government on Wednesday passed legislation that allows only New Zealand residents to buy homes. In recent years, there have been many anecdotal stories of wealthy foreigners from Silicon Valley and beyond buying ranches in picturesque rural New Zealand as a "bolt hole" or escape option from a turbulent world. There have also been stories of wealthy Chinese buyers outbidding New Zealanders on suburban homes in the main city...

Sign up now!